Pirtobrutinib
Overview
Pirtobrutinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4650485).
API suppliers (2)
Suppliers of Pirtobrutinib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 1 of 2 suppliers.
2 of 2 hold a GMP certificate on record in the EU or UK registers
- MSN Laboratories Private LimitedIndia1 active DMF GMP on record
- DR REDDYS LABORATORIES LTD1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Pirtobrutinib expires 14 Sept 2041 and exclusivity 3 Dec 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 5-amino-3-[4-[[(5-fluoro-2-methoxybenzoyl)amino]methyl]phenyl]-1-[(2S)-1,1,1-trifluoropropan-2-yl]pyrazole-4-carboxamide
- Canonical SMILES
- C[C@@H](C(F)(F)F)N1C(=C(C(=N1)C2=CC=C(C=C2)CNC(=O)C3=C(C=CC(=C3)F)OC)C(=O)N)N
- InChIKey
- FWZAWAUZXYCBKZ-NSHDSACASA-N
Do you supply Pirtobrutinib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.